Osteoboost Chief Scientist Michael Jaasma, PhD and Chief Medical Officer Pamela Peeke, MD MD, MPH, FACP, FACSM met with top endocrinologists and bone health specialists at BHOF’s Interdisciplinary Symposium on Osteoporosis in Washington D.C. April 24-26th 2025.

Osteoboost CEO Laura Yecies and VP of Operations Daniel Beeler demoed the Osteoboost precision vibration therapy device at the ViVE 2025 conference on February 16-19th in Nashville Tennessee.

Osteoboost Chief Product Officer Priya Patel spoke at the Nashville Health Care Council’s Sessions2024 October 7-9 at the Country Music Hall of Fame.

Osteoboost won first place in the seed stage category, and the overall People’s Choice Award, at the 2024 Hitlab Women’s Health Tech event on October 4, 2024.

Team Osteoboost attended the ASBMR 2024 Annual Meeting on September 27-30, 2024 in Toronto, and CEO Laura Yecies presented Osteoboost on the main stage.

Osteoboost Chief Medical Officer Dr. Pamela Peeke presented at the annual American College of Sports Medicine conference, May 28-30, 2024 in Boston.

Osteoboost was represented by CEO Laura Yecies on a panel at Dartmouth on Setember 26, 2024 featuring healthtech leaders exploreing cutting-edge advancements in cancer therapeutics, digital health, and healthcare delivery.

Billed as the biggest industry-led women’s health event, we were proud to present Osteoboost and participate in panel discussions at the Women’s Health Innovation Summit in Boston from September 23-25, 2024.

Osteoboost Michael Jaasma | Chief Scientific Officer presented at the What’s Next Longevity Venture Summit 2024, June 11-12, 2024 in San Francisco.

Osteoboost Chief Scientific Officer Michael Jaasma presented at the National Institute on Aging 2024 event in June, 2024.

Osteoboost CEO Laura Yecies presented at Device Talks East, a medtech conference held May 1-2 2024 in Boston.

CEO Laura Yecies presented Osteoboost at the AgeTech Collaborative from AARP startup pitch event in May 2024, and later joined the accelerator.

Laura Yecies presented Osteoboost at the LSI USA ‘24 Emerging Medtech Summit in Dana Point, California, March 18-22, 2024.

The Osteoboost clinical data poster was presented at ASBMR 2023, October 13-16 in Vancouver, BC, and the team met with attendees at our booth.

Out of over 600 entries, Osteoboost won the 2023 Wearables Technologies Innovation World Cup competition, held on August 1, 2024 in San Francisco.

The Osteoboost poster was presented at the 2023 ENDO conference, June 15-18 in Chicago. ENDO is the top global meeting on endocrinology research and clinical care

Osteoboost was presented onstage at LSI Europe 2022, held September 21-24 in Hertfordshire, UK.

Laura Yecies presented Osteoboost at the LSI USA ‘21 Emerging Medtech Summit in Dana Point, CaliforniaDana Point, CA, May 11-13, 2021.

Osteoboost won the Grand Prize in the 2021 Harvard Business School New Venture Competition on March 30, 2021 (virtual event).

Osteoboost won the Jeff Crowe ’78 Grand Prize at the Finale of the 2021 Dartmouth DEF Pitch Competition in March, 2021.